May 29
10:30 am - 11:30 am EDT

LOCAL TIME

Optimizing the clinical research workforce - An industry analysis by Parexel

The biopharmaceutical industry is continually evolving, with new challenges constantly arising that demand innovative solutions. Faced with increasingly complex clinical trials, mounting time and cost pressures, and the explosive growth of data, traditional approaches to research and development have found it challenging to stay ahead. While innovative solutions, including new technologies like artificial intelligence (AI), are addressing these growing issues, staying ahead of the emerging trends and changes within the industry requires a new level of agility and problem solving – necessitating the transformation of our workforce. Executing novel trial designs, understanding and being proficient in using different resource models, and knowing how to leverage AI insights requires a more robust workforce who possess multifaceted, broader expertise. The question remains, is the biopharmaceutical industry ready and equipped to meet these changing dynamics?

Join Endpoints to learn more about Parexel’s new industry research analysis that explores the trends impacting the clinical research workforce and actionable steps that the biopharmaceutical industry can take to create and prepare strong human capital, instill positive culture, and optimize talent delivery models so that drug sponsors can meet these evolving trends.

register now
register for the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from Endpoints News and/or the sponsor(s). View how we use your data here.

If you are experiencing problems with your registration, please try the Zoom registration page.

Stephen Pyke

Stephen Pyke

Chief Clinical Data & Digital Officer, Parexel

Stephen Pyke is the Chief Clinical Data & Digital Officer for Parexel, leading and directing the company’s patient data and AI strategies. Stephen is a statistically trained, quantitative thinker with a deep and highly strategic understanding of patient data, drug development and operational delivery.

Prior to joining Parexel, Stephen was Senior Vice President & Development Head, Digital Data & Analytics at GSK. In this role, he led the company’s efforts to rapidly deliver a tech-enabled modernization and innovation program enabling better use of clinical data as well as productivity and efficiency gains to yield a step change in clinical trial cycle acceleration. Previously, he also held a number of senior leadership roles in R&D with GSK and Pfizer.

In February 2025, Stephen was appointed to the Executive Committee for the Clinical Trials Transformation Initiative (CTTI), a collaborative enterprise informed by individuals and organizations working towards improving the quality and efficiency of clinical trials. Stephen is also on the Board of the Clinical Research Data Sharing Alliance (CRDSA), a multi-stakeholder consortium that serves the clinical data-sharing ecosystem, as well as Chair of the Association of Clinical Research Organization’s (ACRO) AI/ML Committee. During the past 20 years he has also been honored to hold Board positions with several notable professional societies and not-for-profits, including CDISC (Clinical Data Interchange Standards Consortium; Chair), RSS (Royal Statistical Society; VP) and PSI (Statisticians in the Pharmaceutical Industry; Chair).

Stephen holds a Master in Statistics from Imperial College London and a Bachelor in Mathematics from the University of York.

Jenny Denney

Jenny Denney

Executive Vice President, Global Head Parexel FSP, Parexel

Jenny Denney is Executive Vice President and Global Head of FSP Clinical and Biometrics. In this role, she provides leadership and strategic direction to Parexel’s Clinical and Biometrics business leading diverse functional teams of over 3,000 employees worldwide.

Jenny is a seasoned biopharmaceutical executive with over 25 years of experience in clinical research and development, commercial strategy, and senior leadership working with CROs, large pharma, and biotech across all delivery models.

As Senior Vice President and head of Strategic Clinical Leadership of Global Clinical Operations (GCO) at Parexel, she led the clinical strategy and oversight for the company’s top partnership accounts. This included developing the infrastructure to manage the complex transition of work from Full Service to FSP for top global pharmaceutical companies. During her career, Jenny has been involved with multiple NDA submissions and regulatory authority inspections.

She is a key member of the Drug Information Association (DIA) Regional Advisory Council providing expert consultation and insight into the healthcare ecosystem across political, economic, social, technological, environmental, and legal factors to develop a future looking landscape.

Jenny has an MBA with a concentration in biopharmaceutical management and a PMP certification. Her undergraduate degrees are in biochemistry, chemistry, and genetics. She serves on the Board of Directors for the Museum of Life and Science in North Carolina connecting her passion for the sciences to philanthropy work to inspire the next generation of scientists. She is based near Parexel’s corporate headquarters in Durham, NC.

Jaime Green
moderator

Jaime Green

Freelance Journalist & Science Writer

Jaime Green is a freelance science writer and author. Her work has appeared in The New York Times Magazine, The Atlantic, Aeon, Popular Science, Slate, Astrobites, and elsewhere. She is the series editor of The Best American Science and Nature Writing and author of The Possibility of Life: Science, Imagination, and Our Quest for Kinship in the Cosmos.